Quarterly report pursuant to Section 13 or 15(d)

Related Party Agreements (Details)

v3.23.3
Related Party Agreements (Details)
 1 Months Ended 3 Months Ended 9 Months Ended
Mar. 17, 2015
USD ($)
item
Dec. 31, 2016
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Fortress Biotech, Inc | Founders Agreement            
Related Party Agreements            
Long term debt $ 2,800,000          
Issuance of common stock, percentage of outstanding diluted equity 2.50%          
Number of business days 5 days          
Voting equity, percentage of equity or debt financing 2.50%          
Cash fee, percentage of annual net sales 4.50%          
Cash fees, maximum number of days 90 days          
Control fees, number of times | item 5          
Control fees, monthly net sales 12 months          
Cash fee, percentage of monthly net sales 4.50%          
Agreement term 15 years          
Agreement renewal term 1 year          
Fortress Biotech, Inc | Management Services Agreement            
Related Party Agreements            
Number of period 5 years          
Annual consulting fee $ 500,000          
Increase in annual consulting fee 1,000,000.0          
Excess in net assets value $ 100,000,000          
Agreement extension term 5 years          
Costs and expenses, related party     $ 125,000 $ 125,000 $ 375,000 $ 375,000
Caribe Bioadvisors LLC            
Related Party Agreements            
Annual advisory service fee   $ 60,000        
Costs and expenses, related party     28,000 28,000 83,000 83,000
Caribe Bioadvisors LLC | Equity Incentive Grants            
Related Party Agreements            
Costs and expenses, related party     $ 13,000 $ 13,000 $ 37,000 $ 37,000